3rd-Qtr Rx Drug Prices Up 2.9%, Generics Fall 6.4%

25 November 1997

US prescription drug prices rose 2.9% overall in third-quarter 1997,compared with third-quarter 1996, says IMS America's Quarterly Pricing Report. Brand-name drug prices grew 3.8%, while generics' prices fell 6.4%, the lowest rate in three years.

Generic drug prices fell at double-digit levels for most of 1995, 1996 and into first-quarter 1997, with a fall of 8.8% in second-quarter 1997. For branded drugs, the rate of rise is the same as in the first quarter of this year, and 0.4 percentage point higher than the second-quarter rate.

Prescription drugs' overall price growth was 2.3% in both 1997 first and second quarters, and at or below 2% for all of 1996. The Bureau of Labor Statistics says the industry-weighted Producer Price Index rose 2.7% in September 1997 vs September 1996, while the Consumer Price Index for all items rose 2.2%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight